Gokul Keruji Deshmukh

Title: Gokul Keruji Deshmukh: Innovator in CRAC Modulation

Introduction

Gokul Keruji Deshmukh is a prominent inventor based in Maharashtra, India. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that modulate calcium release-activated calcium (CRAC) channels. With a total of six patents to his name, Deshmukh is recognized for his innovative approaches to treating various diseases and disorders.

Latest Patents

Deshmukh's latest patents include groundbreaking work on oxazoline and isoxazoline derivatives as CRAC modulators. This invention relates to compounds of Formula (I) and outlines processes for their preparation, which are useful for treating, preventing, and managing diseases associated with CRAC modulation. Another notable patent involves chromane and chromene derivatives, which are also used as CRAC modulators. This invention details the compounds of Formula (I) and their pharmaceutically acceptable salts, emphasizing their application in medicine for treating disorders linked to CRAC channel modulation.

Career Highlights

Gokul Keruji Deshmukh is currently associated with Lupin, Inc., a leading pharmaceutical company. His work at Lupin has allowed him to focus on innovative research and development, contributing to the advancement of medical treatments through his patented inventions.

Collaborations

Deshmukh has collaborated with notable colleagues, including Nageswara Rao Irlapati and Neelima Sinha. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.

Conclusion

Gokul Keruji Deshmukh stands out as a key figure in the realm of pharmaceutical innovation, particularly in the modulation of CRAC channels. His contributions through patents and collaborations highlight his commitment to advancing medical science and improving patient outcomes.